chitosan has been researched along with epirubicin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, T; Kawashima, Y; Shimabayashi, S | 1 |
| Li, R; Liu, L; Tu, S; Wang, Y; Yang, X; Zhang, Q | 1 |
| Chang, YC; Grumezescu, AM; Huang, KS; Kung, CP; Lin, IY; Lin, YS; Wang, CY; Wang, WT; Weng, WJ; Yang, CH | 1 |
| Kazem, A; Nafee, N; Nasr, M; Saad, H | 1 |
| Cai, X; Chen, H; Jia, Y; Lv, F; Nan, W; Qin, J; Xie, LQ; Yang, W; Zhang, QQ | 1 |
| Abnous, K; Alibolandi, M; Ramezani, M; Taghavi, S; Taghdisi, SM | 1 |
1 review(s) available for chitosan and epirubicin
| Article | Year |
|---|---|
Basic study for stabilization of w/o/w emulsion and its application to transcatheter arterial embolization therapy.
Topics: Animals; Chemoembolization, Therapeutic; Chitin; Chitosan; Drug Stability; Emulsions; Epirubicin; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms, Experimental; Rats | 2000 |
5 other study(ies) available for chitosan and epirubicin
| Article | Year |
|---|---|
Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior.
Topics: Animals; Cattle; Chitosan; Cholesterol; Drug Delivery Systems; Epirubicin; Liposomes; Microscopy, Electron, Transmission; Particle Size | 2010 |
Synthesis and characterization of oil-chitosan composite spheres.
Topics: Chitosan; Epirubicin; Ferric Compounds; Microspheres; Nanoparticles; Particle Size; Plant Oils; Rhodamines; Sunflower Oil | 2013 |
Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Survival; Chitosan; Disease Models, Animal; Drug Delivery Systems; Epirubicin; Glutathione; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Lipid Peroxidation; Liver; Liver Neoplasms; Mice; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Superoxide Dismutase; Tocotrienols; Tumor Suppressor Protein p53 | 2014 |
Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Topics: Animals; Antibiotics, Antineoplastic; Biotinylation; Breast Neoplasms; Carbocyanines; Cell Survival; Chitosan; Endocytosis; Epirubicin; Humans; Kinetics; Lactic Acid; MCF-7 Cells; Mice, Nude; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Photoelectron Spectroscopy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Xenograft Model Antitumor Assays | 2016 |
Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Topics: Adsorption; Animals; Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Survival; Chitosan; CHO Cells; Colonic Neoplasms; Cricetulus; Drug Carriers; Drug Compounding; Drug Liberation; Epirubicin; Female; Humans; Lactic Acid; MCF-7 Cells; Mice, Inbred BALB C; Mucin-1; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Burden | 2017 |